Literature DB >> 10725194

Glycoprotein B of human herpesvirus 8 is a component of the virion in a cleaved form composed of amino- and carboxyl-terminal fragments.

A Baghian1, M Luftig, J B Black, Y X Meng, C P Pau, T Voss, P E Pellett, K G Kousoulas.   

Abstract

Human herpesvirus 8 (HHV-8) or Kaposi's sarcoma-associated herpesvirus (KSHV) is the only known human member of the Rhadinovirus genus of the gammaherpesvirus subfamily. Antibodies against peptides representing portions of the amino- and carboxyl-termini of HHV-8 gB were produced and used to detect gB expression in Vero cells transfected with the gB gene, in the HHV-8-harboring cell line, BCBL-1, and in purified virions. Expression of gB was detected in approximately 3% of uninduced BCBL-1 cells, while up to 30% of the cells expressed gB after 12-O-tetradecanoylphorbol-13-acetate (TPA) induction of virus replication. Indirect immunofluorescence assays and confocal microscopy showed that gB was distributed throughout the cytoplasm of BCBL-1 cells and transfected Vero cells. Immunoblot analyses of virion preparations revealed the presence of full-length as well as two smaller than full-length gB-derived species corresponding to the amino- and carboxy-terminal portions of gB, respectively. Biochemical analysis of the gB carbohydrate moieties using glycosylation inhibitors revealed that gB contained N-linked oligosaccharides of the high-mannose type, characteristic of precursor carbohydrate chains added in the endoplasmic reticulum. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10725194     DOI: 10.1006/viro.2000.0198

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  27 in total

1.  Proteins of purified Epstein-Barr virus.

Authors:  Eric Johannsen; Micah Luftig; Michael R Chase; Steve Weicksel; Ellen Cahir-McFarland; Diego Illanes; David Sarracino; Elliott Kieff
Journal:  Proc Natl Acad Sci U S A       Date:  2004-11-08       Impact factor: 11.205

2.  Virion proteins of Kaposi's sarcoma-associated herpesvirus.

Authors:  Fan Xiu Zhu; Jae Min Chong; Lijun Wu; Yan Yuan
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

3.  Cleavage of Epstein-Barr virus glycoprotein B is required for full function in cell-cell fusion with both epithelial and B cells.

Authors:  Jessica Sorem; Richard Longnecker
Journal:  J Gen Virol       Date:  2009-03       Impact factor: 3.891

4.  Comparison of serologic assays for detection of antibodies against human herpesvirus 8.

Authors:  J L Corchero; E C Mar; T J Spira; P E Pellett; N Inoue
Journal:  Clin Diagn Lab Immunol       Date:  2001-09

5.  Kaposi's sarcoma-associated herpesvirus glycoproteins B and K8.1 regulate virion egress and synthesis of vascular endothelial growth factor and viral interleukin-6 in BCBL-1 cells.

Authors:  R Subramanian; I Sehgal; O D'Auvergne; K G Kousoulas
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

Review 6.  Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells.

Authors:  Bala Chandran
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

7.  Cytokine production by human herpesvirus 8-infected dendritic cells.

Authors:  Heather R Hensler; Giovanna Rappocciolo; Charles R Rinaldo; Frank J Jenkins
Journal:  J Gen Virol       Date:  2009-01       Impact factor: 3.891

8.  Intracellular localization map of human herpesvirus 8 proteins.

Authors:  Gaby Sander; Andreas Konrad; Mathias Thurau; Effi Wies; Rene Leubert; Elisabeth Kremmer; Holger Dinkel; Thomas Schulz; Frank Neipel; Michael Stürzl
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

9.  The cytoplasmic terminus of Kaposi's sarcoma-associated herpesvirus glycoprotein B is not essential for virion egress and infectivity.

Authors:  R Subramanian; O D'Auvergne; Haixia Kong; K G Kousoulas
Journal:  J Virol       Date:  2008-05-14       Impact factor: 5.103

10.  Human herpesvirus 8 glycoprotein B binds the entry receptor DC-SIGN.

Authors:  Heather R Hensler; Monica J Tomaszewski; Giovanna Rappocciolo; Charles R Rinaldo; Frank J Jenkins
Journal:  Virus Res       Date:  2014-07-11       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.